Summary

Fortis Healthcare Ltd., amongst India’s leading healthcare delivery companies, announced its unaudited consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported a 17.5% YoY increase in revenues and a 34.8% increase in operating EBITDA. The hospital business revenues increased by 19.4% YoY and the operating EBITDA margin was at 21.7%. The diagnostics business revenues increased by 8.3% YoY and the operating EBITDA margin was at 23.1%.

Key Highlights

1. 1

   Consolidated Revenues at INR 2,265 Cr, up 17.5% YoY

2. 2

   Operating EBITDA increases 34.8%, margin at 22.3% vs 19.4% in Q3 FY25

3. 3

   Profit Before Tax (before exceptional items) at INR 312 Cr, up 21.9% YoY

4. 4

   Hospital Business Revenues at INR 1,938 Cr, up 19.4% YoY

5. 5

   Operating EBITDA increases 28.9%, margin at 21.7% vs 20.0% in Q3 FY25

6. 6

   Diagnostics Business (INR Cr) Q3FY25 | a3FY26 | 9MFY25 | 9MFY26 | Revenue 342 371 8.3% 1,058 1,139 7.7%

7. 7

   Operating EBITDA Margin 21.3% for Q3 FY25 and 21.4% for 9MFY25

8. 8

   Company’s net debt as of 31 December 2025 stood at INR 2,547 Cr with a Net Debt to EBITDA of 1.24x vs 0.41x as on 31 December 2024

9. 9

   Hospital Business KPIs Q3 FY25 Q3 FY26 9M FY25 9M FY26 Occupancy 67% 67% 69% 69%

10. 10

    Agilus conducted ~9.94 Mn tests versus ~9.59 Mn tests in Q3 FY25

11. 11

    Total CTPs as on 31 December 2025 stood at 4,370